News & Events about Kinnate Biopharma Inc.
Globe Newswire
9 months ago
SAN FRANCISCO and SAN DIEGO, April 18, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (Kinnate), a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers, today announced that the ...
JPMorgan Chase & Co. increased its stake in Kinnate Biopharma Inc. (NASDAQ:KNTE) by 60.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,147 shares of the companys stock after acquiring an additional 3,079 shares during the period. JPMorgan Chase...
JPMorgan Chase & Co. grew its position in shares of Kinnate Biopharma Inc. (NASDAQ:KNTE) by 60.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,147 shares of the companys stock after acquiring an additional 3,079 shares during the ...